Pharma & Healthcare
Global Respiratory Drugs Market Research Report 2025
- Sep 09, 25
- ID: 497618
- Pages: 83
- Figures: 80
- Views: 3
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drugs.
The Respiratory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
FibroGen
Amgen
Dr. Reddy's Laboratories
Afferent Pharmaceuticals
Dainippon Sumitomo
Abbott
Horizon Pharma
Amgen
Pfizer
Segment by Type
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis
Segment by Application
Hospitals
Ambulatory Care
Others
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Respiratory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drugs.
The Respiratory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
FibroGen
Amgen
Dr. Reddy's Laboratories
Afferent Pharmaceuticals
Dainippon Sumitomo
Abbott
Horizon Pharma
Amgen
Pfizer
Segment by Type
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis
Segment by Application
Hospitals
Ambulatory Care
Others
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Respiratory Drugs Market Overview
1.1 Product Definition
1.2 Respiratory Drugs by Type
1.2.1 Global Respiratory Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease
1.2.4 Idiopathic Pulmonary Fibrosis
1.2.5 Cystic Fibrosis
1.3 Respiratory Drugs by Application
1.3.1 Global Respiratory Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.3.4 Others
1.4 Global Respiratory Drugs Market Size Estimates and Forecasts
1.4.1 Global Respiratory Drugs Revenue 2020-2031
1.4.2 Global Respiratory Drugs Sales 2020-2031
1.4.3 Global Respiratory Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Respiratory Drugs Market Competition by Manufacturers
2.1 Global Respiratory Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Respiratory Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Respiratory Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Respiratory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Drugs, Product Type & Application
2.7 Global Key Manufacturers of Respiratory Drugs, Date of Enter into This Industry
2.8 Global Respiratory Drugs Market Competitive Situation and Trends
2.8.1 Global Respiratory Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Respiratory Drugs Players Market Share by Revenue
2.8.3 Global Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Respiratory Drugs Market Scenario by Region
3.1 Global Respiratory Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Respiratory Drugs Sales by Region: 2020-2031
3.2.1 Global Respiratory Drugs Sales by Region: 2020-2025
3.2.2 Global Respiratory Drugs Sales by Region: 2026-2031
3.3 Global Respiratory Drugs Revenue by Region: 2020-2031
3.3.1 Global Respiratory Drugs Revenue by Region: 2020-2025
3.3.2 Global Respiratory Drugs Revenue by Region: 2026-2031
3.4 North America Respiratory Drugs Market Facts & Figures by Country
3.4.1 North America Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Respiratory Drugs Sales by Country (2020-2031)
3.4.3 North America Respiratory Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Respiratory Drugs Market Facts & Figures by Country
3.5.1 Europe Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Respiratory Drugs Sales by Country (2020-2031)
3.5.3 Europe Respiratory Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Respiratory Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Respiratory Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Respiratory Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Respiratory Drugs Market Facts & Figures by Country
3.7.1 Latin America Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Respiratory Drugs Sales by Country (2020-2031)
3.7.3 Latin America Respiratory Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Respiratory Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Respiratory Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Drugs Sales by Type (2020-2031)
4.1.1 Global Respiratory Drugs Sales by Type (2020-2025)
4.1.2 Global Respiratory Drugs Sales by Type (2026-2031)
4.1.3 Global Respiratory Drugs Sales Market Share by Type (2020-2031)
4.2 Global Respiratory Drugs Revenue by Type (2020-2031)
4.2.1 Global Respiratory Drugs Revenue by Type (2020-2025)
4.2.2 Global Respiratory Drugs Revenue by Type (2026-2031)
4.2.3 Global Respiratory Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Respiratory Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Respiratory Drugs Sales by Application (2020-2031)
5.1.1 Global Respiratory Drugs Sales by Application (2020-2025)
5.1.2 Global Respiratory Drugs Sales by Application (2026-2031)
5.1.3 Global Respiratory Drugs Sales Market Share by Application (2020-2031)
5.2 Global Respiratory Drugs Revenue by Application (2020-2031)
5.2.1 Global Respiratory Drugs Revenue by Application (2020-2025)
5.2.2 Global Respiratory Drugs Revenue by Application (2026-2031)
5.2.3 Global Respiratory Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Respiratory Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 FibroGen
6.1.1 FibroGen Company Information
6.1.2 FibroGen Description and Business Overview
6.1.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 FibroGen Respiratory Drugs Product Portfolio
6.1.5 FibroGen Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Respiratory Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Company Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Afferent Pharmaceuticals
6.4.1 Afferent Pharmaceuticals Company Information
6.4.2 Afferent Pharmaceuticals Description and Business Overview
6.4.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Afferent Pharmaceuticals Respiratory Drugs Product Portfolio
6.4.5 Afferent Pharmaceuticals Recent Developments/Updates
6.5 Dainippon Sumitomo
6.5.1 Dainippon Sumitomo Company Information
6.5.2 Dainippon Sumitomo Description and Business Overview
6.5.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dainippon Sumitomo Respiratory Drugs Product Portfolio
6.5.5 Dainippon Sumitomo Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Company Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbott Respiratory Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Horizon Pharma
6.7.1 Horizon Pharma Company Information
6.7.2 Horizon Pharma Description and Business Overview
6.7.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Horizon Pharma Respiratory Drugs Product Portfolio
6.7.5 Horizon Pharma Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amgen Respiratory Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Respiratory Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Drugs Industry Chain Analysis
7.2 Respiratory Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Drugs Production Mode & Process Analysis
7.4 Respiratory Drugs Sales and Marketing
7.4.1 Respiratory Drugs Sales Channels
7.4.2 Respiratory Drugs Distributors
7.5 Respiratory Drugs Customer Analysis
8 Respiratory Drugs Market Dynamics
8.1 Respiratory Drugs Industry Trends
8.2 Respiratory Drugs Market Drivers
8.3 Respiratory Drugs Market Challenges
8.4 Respiratory Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Respiratory Drugs by Type
1.2.1 Global Respiratory Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease
1.2.4 Idiopathic Pulmonary Fibrosis
1.2.5 Cystic Fibrosis
1.3 Respiratory Drugs by Application
1.3.1 Global Respiratory Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.3.4 Others
1.4 Global Respiratory Drugs Market Size Estimates and Forecasts
1.4.1 Global Respiratory Drugs Revenue 2020-2031
1.4.2 Global Respiratory Drugs Sales 2020-2031
1.4.3 Global Respiratory Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Respiratory Drugs Market Competition by Manufacturers
2.1 Global Respiratory Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Respiratory Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Respiratory Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Respiratory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Drugs, Product Type & Application
2.7 Global Key Manufacturers of Respiratory Drugs, Date of Enter into This Industry
2.8 Global Respiratory Drugs Market Competitive Situation and Trends
2.8.1 Global Respiratory Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Respiratory Drugs Players Market Share by Revenue
2.8.3 Global Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Respiratory Drugs Market Scenario by Region
3.1 Global Respiratory Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Respiratory Drugs Sales by Region: 2020-2031
3.2.1 Global Respiratory Drugs Sales by Region: 2020-2025
3.2.2 Global Respiratory Drugs Sales by Region: 2026-2031
3.3 Global Respiratory Drugs Revenue by Region: 2020-2031
3.3.1 Global Respiratory Drugs Revenue by Region: 2020-2025
3.3.2 Global Respiratory Drugs Revenue by Region: 2026-2031
3.4 North America Respiratory Drugs Market Facts & Figures by Country
3.4.1 North America Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Respiratory Drugs Sales by Country (2020-2031)
3.4.3 North America Respiratory Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Respiratory Drugs Market Facts & Figures by Country
3.5.1 Europe Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Respiratory Drugs Sales by Country (2020-2031)
3.5.3 Europe Respiratory Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Respiratory Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Respiratory Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Respiratory Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Respiratory Drugs Market Facts & Figures by Country
3.7.1 Latin America Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Respiratory Drugs Sales by Country (2020-2031)
3.7.3 Latin America Respiratory Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Respiratory Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Respiratory Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Drugs Sales by Type (2020-2031)
4.1.1 Global Respiratory Drugs Sales by Type (2020-2025)
4.1.2 Global Respiratory Drugs Sales by Type (2026-2031)
4.1.3 Global Respiratory Drugs Sales Market Share by Type (2020-2031)
4.2 Global Respiratory Drugs Revenue by Type (2020-2031)
4.2.1 Global Respiratory Drugs Revenue by Type (2020-2025)
4.2.2 Global Respiratory Drugs Revenue by Type (2026-2031)
4.2.3 Global Respiratory Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Respiratory Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Respiratory Drugs Sales by Application (2020-2031)
5.1.1 Global Respiratory Drugs Sales by Application (2020-2025)
5.1.2 Global Respiratory Drugs Sales by Application (2026-2031)
5.1.3 Global Respiratory Drugs Sales Market Share by Application (2020-2031)
5.2 Global Respiratory Drugs Revenue by Application (2020-2031)
5.2.1 Global Respiratory Drugs Revenue by Application (2020-2025)
5.2.2 Global Respiratory Drugs Revenue by Application (2026-2031)
5.2.3 Global Respiratory Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Respiratory Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 FibroGen
6.1.1 FibroGen Company Information
6.1.2 FibroGen Description and Business Overview
6.1.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 FibroGen Respiratory Drugs Product Portfolio
6.1.5 FibroGen Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Respiratory Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Company Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Afferent Pharmaceuticals
6.4.1 Afferent Pharmaceuticals Company Information
6.4.2 Afferent Pharmaceuticals Description and Business Overview
6.4.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Afferent Pharmaceuticals Respiratory Drugs Product Portfolio
6.4.5 Afferent Pharmaceuticals Recent Developments/Updates
6.5 Dainippon Sumitomo
6.5.1 Dainippon Sumitomo Company Information
6.5.2 Dainippon Sumitomo Description and Business Overview
6.5.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dainippon Sumitomo Respiratory Drugs Product Portfolio
6.5.5 Dainippon Sumitomo Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Company Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbott Respiratory Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Horizon Pharma
6.7.1 Horizon Pharma Company Information
6.7.2 Horizon Pharma Description and Business Overview
6.7.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Horizon Pharma Respiratory Drugs Product Portfolio
6.7.5 Horizon Pharma Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amgen Respiratory Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Respiratory Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Drugs Industry Chain Analysis
7.2 Respiratory Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Drugs Production Mode & Process Analysis
7.4 Respiratory Drugs Sales and Marketing
7.4.1 Respiratory Drugs Sales Channels
7.4.2 Respiratory Drugs Distributors
7.5 Respiratory Drugs Customer Analysis
8 Respiratory Drugs Market Dynamics
8.1 Respiratory Drugs Industry Trends
8.2 Respiratory Drugs Market Drivers
8.3 Respiratory Drugs Market Challenges
8.4 Respiratory Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Respiratory Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Respiratory Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Respiratory Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Respiratory Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Respiratory Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Respiratory Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Respiratory Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Respiratory Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Respiratory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Respiratory Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Respiratory Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Respiratory Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Respiratory Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Respiratory Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Respiratory Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Respiratory Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Respiratory Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Respiratory Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Respiratory Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Respiratory Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Respiratory Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Respiratory Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Respiratory Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Respiratory Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Respiratory Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Respiratory Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Respiratory Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Respiratory Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Respiratory Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Respiratory Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Respiratory Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Respiratory Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Respiratory Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Respiratory Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Respiratory Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Respiratory Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Respiratory Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Respiratory Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Respiratory Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Respiratory Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Respiratory Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Respiratory Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Respiratory Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Respiratory Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Respiratory Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. FibroGen Company Information
Table 71. FibroGen Description and Business Overview
Table 72. FibroGen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. FibroGen Respiratory Drugs Product
Table 74. FibroGen Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Amgen Respiratory Drugs Product
Table 79. Amgen Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Company Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Dr. Reddy's Laboratories Respiratory Drugs Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Afferent Pharmaceuticals Company Information
Table 86. Afferent Pharmaceuticals Description and Business Overview
Table 87. Afferent Pharmaceuticals Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Afferent Pharmaceuticals Respiratory Drugs Product
Table 89. Afferent Pharmaceuticals Recent Developments/Updates
Table 90. Dainippon Sumitomo Company Information
Table 91. Dainippon Sumitomo Description and Business Overview
Table 92. Dainippon Sumitomo Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dainippon Sumitomo Respiratory Drugs Product
Table 94. Dainippon Sumitomo Recent Developments/Updates
Table 95. Abbott Company Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abbott Respiratory Drugs Product
Table 99. Abbott Recent Developments/Updates
Table 100. Horizon Pharma Company Information
Table 101. Horizon Pharma Description and Business Overview
Table 102. Horizon Pharma Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Horizon Pharma Respiratory Drugs Product
Table 104. Horizon Pharma Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Amgen Respiratory Drugs Product
Table 109. Amgen Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Respiratory Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Respiratory Drugs Distributors List
Table 118. Respiratory Drugs Customers List
Table 119. Respiratory Drugs Market Trends
Table 120. Respiratory Drugs Market Drivers
Table 121. Respiratory Drugs Market Challenges
Table 122. Respiratory Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Respiratory Drugs
Figure 2. Global Respiratory Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Respiratory Drugs Market Share by Type: 2024 & 2031
Figure 4. Asthma Product Picture
Figure 5. Chronic Obstructive Pulmonary Disease Product Picture
Figure 6. Idiopathic Pulmonary Fibrosis Product Picture
Figure 7. Cystic Fibrosis Product Picture
Figure 8. Global Respiratory Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Respiratory Drugs Market Share by Application: 2024 & 2031
Figure 10. Hospitals
Figure 11. Ambulatory Care
Figure 12. Others
Figure 13. Global Respiratory Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Respiratory Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Respiratory Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Respiratory Drugs Average Price (USD/Unit) & (2020-2031)
Figure 17. Respiratory Drugs Report Years Considered
Figure 18. Respiratory Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Respiratory Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Respiratory Drugs Players: Market Share by Revenue in Respiratory Drugs in 2024
Figure 21. Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Respiratory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Mexico Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. UK Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Respiratory Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Respiratory Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Vietnam Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Respiratory Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Respiratory Drugs by Type (2020-2031)
Figure 59. Global Respiratory Drugs Price (USD/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Respiratory Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Respiratory Drugs by Application (2020-2031)
Figure 62. Global Respiratory Drugs Price (USD/Unit) by Application (2020-2031)
Figure 63. Respiratory Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Respiratory Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Respiratory Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Respiratory Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Respiratory Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Respiratory Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Respiratory Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Respiratory Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Respiratory Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Respiratory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Respiratory Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Respiratory Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Respiratory Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Respiratory Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Respiratory Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Respiratory Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Respiratory Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Respiratory Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Respiratory Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Respiratory Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Respiratory Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Respiratory Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Respiratory Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Respiratory Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Respiratory Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Respiratory Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Respiratory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Respiratory Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Respiratory Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Respiratory Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Respiratory Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Respiratory Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Respiratory Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Respiratory Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Respiratory Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Respiratory Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Respiratory Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Respiratory Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Respiratory Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Respiratory Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Respiratory Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Respiratory Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Respiratory Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Respiratory Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Respiratory Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Respiratory Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Respiratory Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Respiratory Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Respiratory Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Respiratory Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Respiratory Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. FibroGen Company Information
Table 71. FibroGen Description and Business Overview
Table 72. FibroGen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. FibroGen Respiratory Drugs Product
Table 74. FibroGen Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Amgen Respiratory Drugs Product
Table 79. Amgen Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Company Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Dr. Reddy's Laboratories Respiratory Drugs Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Afferent Pharmaceuticals Company Information
Table 86. Afferent Pharmaceuticals Description and Business Overview
Table 87. Afferent Pharmaceuticals Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Afferent Pharmaceuticals Respiratory Drugs Product
Table 89. Afferent Pharmaceuticals Recent Developments/Updates
Table 90. Dainippon Sumitomo Company Information
Table 91. Dainippon Sumitomo Description and Business Overview
Table 92. Dainippon Sumitomo Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dainippon Sumitomo Respiratory Drugs Product
Table 94. Dainippon Sumitomo Recent Developments/Updates
Table 95. Abbott Company Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abbott Respiratory Drugs Product
Table 99. Abbott Recent Developments/Updates
Table 100. Horizon Pharma Company Information
Table 101. Horizon Pharma Description and Business Overview
Table 102. Horizon Pharma Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Horizon Pharma Respiratory Drugs Product
Table 104. Horizon Pharma Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Amgen Respiratory Drugs Product
Table 109. Amgen Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Respiratory Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Respiratory Drugs Distributors List
Table 118. Respiratory Drugs Customers List
Table 119. Respiratory Drugs Market Trends
Table 120. Respiratory Drugs Market Drivers
Table 121. Respiratory Drugs Market Challenges
Table 122. Respiratory Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Respiratory Drugs
Figure 2. Global Respiratory Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Respiratory Drugs Market Share by Type: 2024 & 2031
Figure 4. Asthma Product Picture
Figure 5. Chronic Obstructive Pulmonary Disease Product Picture
Figure 6. Idiopathic Pulmonary Fibrosis Product Picture
Figure 7. Cystic Fibrosis Product Picture
Figure 8. Global Respiratory Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Respiratory Drugs Market Share by Application: 2024 & 2031
Figure 10. Hospitals
Figure 11. Ambulatory Care
Figure 12. Others
Figure 13. Global Respiratory Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Respiratory Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Respiratory Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Respiratory Drugs Average Price (USD/Unit) & (2020-2031)
Figure 17. Respiratory Drugs Report Years Considered
Figure 18. Respiratory Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Respiratory Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Respiratory Drugs Players: Market Share by Revenue in Respiratory Drugs in 2024
Figure 21. Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Respiratory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Mexico Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. UK Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Respiratory Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Respiratory Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Vietnam Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Respiratory Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Respiratory Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Respiratory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Respiratory Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Respiratory Drugs by Type (2020-2031)
Figure 59. Global Respiratory Drugs Price (USD/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Respiratory Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Respiratory Drugs by Application (2020-2031)
Figure 62. Global Respiratory Drugs Price (USD/Unit) by Application (2020-2031)
Figure 63. Respiratory Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232